Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
7.15
+0.14 (2.00%)
Aug 19, 2026, 4:00 PM EDT - Market closed
Kyntra Bio Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Kyntra Bio stock has a consensus rating of "Buy" and an average price target of $39. The average 1-year stock price forecast is 445.45% higher than the current stock price, while the lowest is $35 (+389.51%) and the highest is $43 (+501.40%).
Price Target: $39 (+445.45%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Kyntra Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Feb '26 | Mar '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $35 | Buy | Maintains | $35 | +389.51% | Aug 14, 2026 |
| William Blair | William Blair | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $43 | Buy | Reiterates | $43 | +501.40% | Aug 14, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $30 | Buy | Initiates | $30 | +319.58% | Jun 9, 2026 |
Financial Forecast
Revenue This Year
6.70M
from 6.44M
Increased by 4.01%
Revenue Next Year
8.14M
from 6.70M
Increased by 21.51%
EPS This Year
-12.41
from 45.37
EPS Next Year
-14.23
from -12.41
EPS and Forward PE are based on non-GAAP adjusted numbers.